Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
LT3968956T - Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui - Google Patents
[go: Go Back, main page]

LT3968956T - Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui - Google Patents

Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui

Info

Publication number
LT3968956T
LT3968956T LTEPPCT/IB2020/059815T LTIB2020059815T LT3968956T LT 3968956 T LT3968956 T LT 3968956T LT IB2020059815 T LTIB2020059815 T LT IB2020059815T LT 3968956 T LT3968956 T LT 3968956T
Authority
LT
Lithuania
Prior art keywords
mupirocin
wounds
treatment
pharmaceutical composition
bacterial infections
Prior art date
Application number
LTEPPCT/IB2020/059815T
Other languages
English (en)
Inventor
Vanangamudi Subramaniam SULUR
Madhavan Srinivasan
Vishagan Vanangamudi SULUR
Original Assignee
Vishagan Vanangamudi SULUR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vishagan Vanangamudi SULUR filed Critical Vishagan Vanangamudi SULUR
Publication of LT3968956T publication Critical patent/LT3968956T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
LTEPPCT/IB2020/059815T 2019-10-24 2020-10-19 Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui LT3968956T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN201941043186 2019-10-24
PCT/IB2020/059815 WO2021079254A1 (en) 2019-10-24 2020-10-19 A topical antibiotic containing pharmaceutical composition for bacterial infections and wound healing

Publications (1)

Publication Number Publication Date
LT3968956T true LT3968956T (lt) 2024-07-10

Family

ID=73198358

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/IB2020/059815T LT3968956T (lt) 2019-10-24 2020-10-19 Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui

Country Status (23)

Country Link
EP (1) EP3968956B1 (lt)
JP (1) JP7441943B2 (lt)
KR (1) KR20220087501A (lt)
CN (1) CN114364370B (lt)
AR (1) AR120293A1 (lt)
AU (1) AU2020369219B2 (lt)
BR (1) BR112022004949A2 (lt)
CA (1) CA3144877A1 (lt)
DK (1) DK3968956T3 (lt)
ES (1) ES2983685T3 (lt)
FI (1) FI3968956T3 (lt)
HR (1) HRP20240841T1 (lt)
HU (1) HUE067704T2 (lt)
LT (1) LT3968956T (lt)
MX (1) MX2022001532A (lt)
PH (1) PH12022550920A1 (lt)
PL (1) PL3968956T3 (lt)
PT (1) PT3968956T (lt)
RS (1) RS65709B1 (lt)
SI (1) SI3968956T1 (lt)
SM (1) SMT202400290T1 (lt)
WO (1) WO2021079254A1 (lt)
ZA (1) ZA202201884B (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025262459A1 (en) * 2024-06-21 2025-12-26 Apex Laboratories Private Limited A fusidic acid gel with chitosan and hydrolyzed collagen for treatment of diabetic ulcers and a process of making it

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137363A (en) 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
WO2010109434A2 (en) * 2009-03-25 2010-09-30 Sulur Subramaniam Vanangamudi A medicinal antibacterial, antifungal and steroids cream and a process to make it
MX2011009934A (es) * 2009-03-25 2011-10-06 Sulur Subramaniam Vanangamudi Crema antibacteriana medicinal y proceso para hacerla.
WO2010122478A1 (en) * 2009-04-20 2010-10-28 Sulur Subramaniam Vanangamudi A medicinal antibacterial and steroids cream incorporating a biopolymer and a process to make it
TWI445557B (zh) * 2011-05-24 2014-07-21 To induce new bone formation around the implant compositions
CN202505827U (zh) * 2012-03-30 2012-10-31 深圳市源兴纳米医药科技有限公司 一种含纳米银的止血消炎抗菌敷贴
GEAP201913925A (en) * 2013-01-30 2019-07-10 Boris Gorinshteyn Compositions and methods for treating surface wounds
KR101457789B1 (ko) * 2013-02-13 2014-11-03 동아제약 주식회사 상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
CN106039394A (zh) * 2016-06-02 2016-10-26 四川奎星医用高分子制品有限责任公司 含有抗菌药物的医用复合壳聚糖凝胶

Also Published As

Publication number Publication date
EP3968956B1 (en) 2024-04-10
KR20220087501A (ko) 2022-06-24
PL3968956T3 (pl) 2024-08-19
BR112022004949A2 (pt) 2022-08-23
ZA202201884B (en) 2022-10-26
CN114364370A (zh) 2022-04-15
AU2020369219B2 (en) 2026-03-05
HUE067704T2 (hu) 2024-11-28
ES2983685T3 (es) 2024-10-24
JP7441943B2 (ja) 2024-03-01
FI3968956T3 (fi) 2024-07-03
US20230190647A1 (en) 2023-06-22
AU2020369219A1 (en) 2022-01-20
JP2023501910A (ja) 2023-01-20
CA3144877A1 (en) 2021-04-29
AR120293A1 (es) 2022-02-09
DK3968956T3 (da) 2024-06-24
PH12022550920A1 (en) 2023-07-10
PT3968956T (pt) 2024-07-15
RS65709B1 (sr) 2024-08-30
MX2022001532A (es) 2022-03-11
HRP20240841T1 (hr) 2024-10-11
SI3968956T1 (sl) 2024-08-30
SMT202400290T1 (it) 2024-09-16
CN114364370B (zh) 2024-09-06
WO2021079254A1 (en) 2021-04-29
EP3968956A1 (en) 2022-03-23

Similar Documents

Publication Publication Date Title
WO2016179440A3 (en) Antimicrobial therapy
MX2023002507A (es) Inhibidores de cd73.
BR112017004889A2 (pt) uso antibacteriano de salicilanilidas halogenadas
MX2022005256A (es) Inhibidores de cd73.
GEAP202215303A (en) Chromane monobactam compounds for the treatment of bacterial infections
WO2017083431A3 (en) Hydroxypyridinone and hydroxypyrimidinone based compounds for treating bacterial infections
WO2016142445A3 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
IL271863B (en) Compounds and use thereof for the treatment of microbial infections
EP3280722B8 (en) Antimicrobial peptides and their use for the treatment of topical infections
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner
EP4262813A4 (en) DRUGS, THERAPEUTIC COMBINATIONS AND METHODS FOR PREVENTING VIRAL AND MICROBIAL INFECTIONS AND THEIR SEQUELAE
WO2017075188A3 (en) Methods of using anti-alpha toxin antibody
LT3820856T (lt) C-manozido junginiai, naudingi šlapimo takų infekcijoms gydyti
HUE057063T2 (hu) Topikális gyógyászati készítmény, amely legalább amitriptilint tartalmaz, perifériás neuropátiás fájdalom kezelésére
LT3630111T (lt) Junginiai ir būdai, skirti bakterinių infekcijų gydymui
BR112016013600A2 (pt) Peptídeo antimicrobiano e seus usos
MX2018006190A (es) Antibioticos de amplio espectro macrociclico.
MX2017012535A (es) Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
MX2017014080A (es) Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas.
EP4364567A4 (en) Antiseptic, antibacterial, and preservative composition
LT3968956T (lt) Vietinė farmacinė mupirocino kompozicija, skirta bakterinių infekcijų ir žaizdų gydymui
EP3634471A4 (en) Carbapenem compounds and compositions for the treatment of bacterial infections
EP4129291A4 (en) CORONAVIRUS INFECTION TREATMENT MEDICATION
MX2021012146A (es) Formulacion de tableta vaginal.
LT3743043T (lt) Farmacinės kompozicijos, skirtos pooperacinio skausmo gydymui